SUMMIT, N.J.--(BUSINESS WIRE)--Jul. 16, 2012--
Celgene Corporation (NASDAQ: CELG) senior management will host a
conference call and live audio webcast on Thursday, July 26, 2012 at 9
a.m. ET to discuss the company’s second quarter 2012 financial and
operational results. The webcast will be available in the investor
relations section of the Company’s Web site at www.celgene.com.
Celgene Corporation, headquartered in Summit, New Jersey, is an
integrated global biopharmaceutical company engaged primarily in the
discovery, development and commercialization of novel therapies for the
treatment of cancer and inflammatory diseases through gene and protein
regulation. For more information, please visit the company’s Web site at www.celgene.com.
Source: Celgene Corporation
Jacqualyn A. Fouse
President and Chief Financial Officer
E. Flanigan III